Position in ABBV
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$45,707,386
+$6,729,481 QoQ
Shares Held
181,638
+1.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
4.68%
of 13F equity value
Holder Rank
#389
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FRANKLIN STREET ADVISORS INC /NC holds $55,471,815 across 7 Drug Manufacturers - General names. ABBV ranks #1 (82.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
181,638 | $45,707,386 | |
| 2 | JNJ |
Johnson & Johnson
|
19,450 | $4,939,716 | |
| 3 | AMGN |
Amgen Inc
|
3,408 | $1,234,104 | |
| 4 | LLY |
ELI LILLY & Co
|
1,009 | $1,210,224 | |
| 5 | PFE |
Pfizer Inc
|
46,667 | $1,123,741 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,476 | $944,517 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,417 | $312,127 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,707,386 | 181,638 | Shares | Defined | 2026-07-09 | |
| 2026-03-31 | $38,977,905 | 179,217 | Shares | Defined | 2026-04-10 | |
| 2025-12-31 | $41,795,619 | 182,921 | Shares | Defined | 2026-01-21 | |
| 2025-09-30 | $41,367,862 | 178,664 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $32,127,852 | 173,084 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $32,617,864 | 155,679 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $28,001,077 | 157,575 | Shares | Defined | 2025-01-10 | |
| 2024-09-30 | $34,293,586 | 173,656 | Shares | Defined | 2024-10-09 | |
| 2024-06-30 | $30,824,202 | 179,712 | Shares | Defined | 2024-07-18 | |
| 2024-03-31 | $34,379,569 | 188,795 | Shares | Defined | 2024-04-15 | |
| 2023-12-31 | $29,717,667 | 191,764 | Shares | Defined | 2024-01-18 | |
| 2023-09-30 | $30,413,009 | 204,032 | Shares | Defined | 2023-10-10 | |
| 2023-06-30 | $25,942,800 | 192,554 | Shares | Defined | 2023-07-13 | |
| 2023-03-31 | $30,988,380 | 194,443 | Shares | Defined | 2023-04-12 | |
| 2022-12-31 | $37,164,320 | 229,963 | Shares | Defined | 2023-02-07 | |
| 2022-09-30 | $29,134,709 | 217,083 | Shares | Defined | 2022-10-11 | |
| 2022-06-30 | $38,967,733 | 254,425 | Shares | Defined | 2022-07-13 | |
| 2022-03-31 | $44,683,676 | 275,638 | Shares | Defined | 2022-04-18 | |
| 2021-12-31 | $45,222,381 | 333,991 | Shares | Defined | 2022-01-26 | |
| 2021-09-30 | $30,760,748 | 285,165 | Shares | Defined | 2021-10-22 | |
| 2021-06-30 | $32,051,486 | 284,548 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $31,890,486 | 294,682 | Shares | Defined | 2021-05-04 | |
| 2020-12-31 | $31,000,316 | 289,317 | Shares | Defined | 2021-02-01 | |
| 2020-09-30 | $24,983,295 | 285,230 | Shares | Defined | 2020-10-21 | |
| 2020-06-30 | $27,392,809 | 279,006 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $21,802,987 | 286,166 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||